Hereditary Angioedema - 34 Studies Found Completed : Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema (HAE) Subjects : Hereditary Angioedema : 2014-03-17 : Drug: DX-2930 DX-2930 is a rec Recruiting : Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema : Hereditary Angioedema Types I and II : 2013-04-04 : Drug: Ecallantide subcutaneous dosing For acute attacks of Hereditary Angioedema in children and adolesc Completed : Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema : 2007-04-04 : Drug: ecallantide dose of 30 m Active, not recruiting : A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema : Hereditary Angioedema (HAE) : 2011-06-28 : Drug: icatibant Single dose of icatibant 0.4 mg/kg subcutaneous(SC) up to a maximal dose of 30 mg Completed : A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema : Hereditary Angioedema (HAE) : 2012-02-16 Completed : Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE) : Hereditary Angioedema (HAE) : 2005-12-05 : Drug: ecallantide dose of 30 m Recruiting : Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema : Hereditary Angioedema (HAE) : 2016-08-10 : Drug: BCX7353 Plasma kallikrei Active, not recruiting : Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema : Hereditary Angioedema (HAE) : 2014-01-30 : Biological: CINRYZE 500 500 Un Active, not recruiting : Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE) : Hereditary Angioedema (HAE) : 2016-08-09 : Drug: CINRYZE 500 U IV infusio Active, not recruiting : A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema : Hereditary Angioedema Types I and II : 2014-12-10 : Biological: C1-esterase inhibitor <<< Previous | Next >>>